General
Preferred name
CISATRACURIUM
Synonyms
CISATRACURIUM BESYLATE ()
51W89 ()
Nimbex ()
atracurium besilate ()
Cisatracurium Besylate ()
Cisatracurium (besylate) ()
51W89 (besylate) ()
Cisatracurium (besilate) ()
Nimbex preservative free ()
Besilate de cisatracurium ()
51-W89 ()
Besilato de cisatracurio ()
51 W89 ()
51-W-89 ()
Cisatracurium besylate preservative free ()
Cisatracurium besilate ()
Cisatracurium (as besilate) ()
51W-89 ()
Cisatracurium cation ()
Cisatracurium ion ()
P&D ID
PD013318
CAS
96946-42-8
96946-41-7
Tags
available
drug
Approved by
FDA
First approval
1995
Drug indication
Muscle spasm
Acute respiratory distress syndrome
Drug Status
approved
investigational
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Cisatracurium is a skeletal muscle relaxant used to facilitate tracheal intubation, muscle relaxation in surgery, or mechanical ventilation. It acts on cholinergic receptors, blocking neuromuscular transmission. (Enamine Bioactive Compounds)
DESCRIPTION Cisatracurium besylate (51W89) is a nondepolarizing skeletal muscle relaxant intended for intravenous administration. (TargetMol Bioactive Compound Library)
Compound Sets
20
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Enamine Bioactive Compounds
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
Natural product-based probes and drugs
NCATS Inxight Approved Drugs
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
56
Properties
(calculated by RDKit )
Molecular Weight
928.51
Hydrogen Bond Acceptors
12
Hydrogen Bond Donors
0
Rotatable Bonds
24
Ring Count
6
Aromatic Ring Count
4
cLogP
8.07
TPSA
126.44
Fraction CSP3
0.51
Chiral centers
4.0
Largest ring
6.0
QED
0.04
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
nicotinic acetylcholine receptor antagonist
acetylcholine receptor antagonist
Target
Muscle-type nicotinic acetylcholine receptor
CHRNA2
nAChR
Adrenergic Receptor
AChR
Pathway
Autophagy
GPCR/G protein
Neuroscience
Membrane Transporter/Ion Channel
Neuronal Signaling
Indication
muscle relaxant, endotracheal intubation
Disease Area
neurology/psychiatry, critical care
Biosynthetic Origin
Alkaloid
Therapeutic Indication
Muscle Relaxant
Therapeutic Class
CNS & PNS
Source data